ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in June 2024. Updated June 30, 2024.
A roundup of FDA’s actions in June 2024.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in June 2024. Updated June 30, 2024.
A roundup of FDA’s actions in June 2024.